{"database": "lobbying", "table": "lobbying_activities", "rows": [[2998235, "9e118751-861f-4629-a7e5-3b02d02c8049", "Q2", "AUBURN HEALTH STRATEGIES, LLC", 292697, "AOAC INTERNATIONAL", 2023, "second_quarter", "CSP", "methods development and quality measurements in analytical sciences for cannabis-derived products and for cosmetics", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-06-30T18:16:06-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2998235"], "units": {}, "query_ms": 132.3324459954165, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}